Regeneron Pharma (REGN) PT Lowered to $950 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $950.00 (from $1,000.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
